According to Roivant Sciences's latest financial reports the company has $6.67 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $1.67 B | -18.62% |
2022-03-31 | $2.06 B | 0.26% |
2021-03-31 | $2.05 B |